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INTRODUCTION
Primary cranial chondrosarcoma is not an uncommon neo-
plasm and usually arises at the synchondroses of the skull
base, particularly the sphenoid bone and the clival basioc-
ciput (1-3). Primary intracranial extraosseous chondrosarco-
ma is rare and most are attached to the dura, the presumed
site of origin of these tumors (4-7). However, seven cases of
primary intracranial chondrosarcomas unrelated to the cranium
or the meninges have been reported and all of these tumors
were histologically typed as mesenchymal variants (3, 5).
Recently, the authors experienced a case of primary intra-
parenchymal myxoid chondrosarcoma of the brain without
any attachment to the cranium or the meninges. We believe
it worthwhile to document the clinical manifestations and
radiological findings of this case, because to the best of our
knowledge, this condition has not been previously reported.
The authors discuss pathologic differential diagnosis between
histologically similar tumors, such as chordoma, parachor-
doma, chordoid meningioma and chordoid glioma for the
meticulous histologic differentiation of tumors, although
cords of epithelioid cells reminiscent of typical chordomas
are not the significant histologic finding in present case.
CASE REPORT
A 43-yr-old man was admitted to the neurosurgery depart-
ment due to a history of occipital headache, nausea, and vom-
iting of two months’ duration. He complained of general
weakness, myalgia, tinnitus in the left ear, and an intermit-
tent tingling sensation in the distribution of the bilateral
mandibular division of the V cranial nerve. He had been man-
aged with an insulin pump due to longstanding diabetes
mellitus, and the generalized vague symptoms, mentioned
previously, were considered to be complications of the diabetes
mellitus. Neurological and physical examinations revealed
no abnormalities. A pre-contrast computed tomography
(CT) scan showed a 2 cm, non-calcified, slightly low density
mass with severe peritumoral edema in the left parietal lobe.
A post-contrast CT scan revealed strong homogeneous en-
hancement of the mass (Fig. 1), which was of low signal
intensity on T1-weighted magnetic resonance (MR) imag-
ing and high signal intensity on T2-weighted MR imag-
ing. Post-contrast MR imaging revealed a homogeneously
enhancing mass in the left parietal lobe (Fig. 2). A bone scan
showed no abnormal uptake. A serum tumor marker study,
performed under the impression of metastatic brain tumor,
was negative for AFP, CEA, CA125, CA19-9, PAP, and PSA.
Whole body 
18F-FDG-PET (positron emission tomography)
showed a focal hypermetabolic lesion in the parietal area,
however, there was no abnormality outside the brain. The
patient underwent a left parietal osteoplastic craniotomy
under the impression of atypical malignant glioma, lym-
phoma, or metastatic tumor. Skull bone and dural surface
looked normal and a cruciate dural incision was made. There
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was no adhesion or attachment between the dura and the
cerebral cortex and the cortical surface also showed a normal
architecture. An incision was made on the surface of the
parietal lobe and a well encapsulated mass was found just
beneath the cortex. The tumor was readily dissected from
the surrounding gliotic plane and an en-bloc removal was
performed. The immediate postoperative course was unevent-
ful. The patient received postoperative radiotherapy of 5,940
cGy in 33 fractions. He remains in good medical condition
and follow-up MR images taken three years after the opera-
tion showed no recurrence.
Pathological Findings
Macroscopically, the tumor had a nodular and lobulated
appearance and measured 1.2×1.0×1.0 cm (Fig. 3). It had
a grayish surface and showed a yellowish gray gelatinous area
on serial section. It was firm to slightly hard in consistency.  
Microscopically, the periphery of the tumor was surrounded
partly by a thin fibrous tissue and partly by a somewhat com-
pressed brain parenchyma. On low power cross-sectional view,
the tumor had paucicellular areas interspersed with areas con-
taining moderate numbers of cellular foci. The tumor showed
an associated basophilic myxoid matrix, separated by thin
Fig. 1. (A) Pre-contrast computed tomography (CT) showing an ill-defined isodense mass (arrows), with severe surrounding edema in the
left parietal cortex. (B) Strong homogeneous enhancement of the mass as seen in postcontrast CT.
A B
Fig. 2. (A) Axial T2-weighted magnetic resonance (MR) image showing slightly high signal intensity mass with severe surrounding edema
in the left parietal cortex (arrow). (B) Sagittal T1-weighted MR image revealing an ill-defined low signal intensity mass (arrow). (C) Strong
homogeneous enhancement of the mass as seen on the axial post-contrast T1-weighted MR image. The mass is located just beneath
the dura, however, there was no connection to the dura.
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connective tissue bands, and was composed of round or slightly
elongated cells separated by abundant myxoid stroma. The
individual cells possessed small hyperchromatic, slightly
irregular nuclei and a narrow rim of deeply eosinophilic cyto-
plasm, and were arranged in short anastomosing cords and
strands in myxoid matrix (Fig. 4, 5). The histology of this
tumor resembled that of an extraskeletal myxoid chondrosar-
coma of other soft tissues. Microscopically, neither hemor-
rhage nor necrosis was observed. Mitoses were extremely rare.
Portions of the tumor contained numerous thin-walled vessels.
The following antibodies were used for immunohistochemi-
cal analyses; a polyclonal antibody to S100 (1:400; Dako A/S,
Glostrup, Denmark) and monoclonal antisera to glial fibril-
lary acidic protein (GFAP) (Dako, 1:500), vimentin (clone V9;
1:100; Dako A/S, Glostrup, Denmark), epithelial membrane
antigen (EMA) (clone E29; 1:50; Dako A/S, Glostrup, Den-
mark), cytokeratin 19 (clone RCK 108; 1:50; Dako A/S,
Glostrup, Denmark), and cytokeratin, high molecular weight
(clone 34 E12; 1:50; Dako A/S, Glostrup, Denmark). Immu-
nohistochemical studies were performed using the avidin-
biotin-peroxidase complex method. Diaminobenzidine was
used as a substrate. On immunohistochemical studies, the
neoplastic cells showed a weak positive staining for S100,
positive staining for vimentin, and a lack of staining for EMA,
cytokeratin 19, GFAP, and high molecular weight cytoker-
atin, which confirmed the diagnosis of myxoid chondrosar-
coma (Fig. 6). 
DISCUSSION
Primary cranial chondrosarcomas normally arise from the
skull base and are usually located extradurally (1-3). Prima-
ry intracranial extraosseous chondrosarcomas have been less
commonly reported than cranial chondrosarcomas and their
locations include the cerebral convexity, falx, fourth ventricle,
Fig. 3. Photomicrograph showing a nodular and lobulated appear-
ance of tumor (H&E, ×10).
Fig. 4. High power photomicrograph of the tumor shows epithe-
lioid to spindle shaped cells dispersed in a myxochondroid matrix
(H&E, ×400).
Fig. 5. Photomicrograph of the tumor cells, which are arranged in
strands and cords within a large amount of stroma. Round or slight-
ly elongated cells are separated by abundant myxoid stroma (H&E,
×200).304 S.-H. Im, D.G. Kim, I.A. Park, et al.
cerebellum, and thalamus (3, 6-10). Theoretically, a chon-
drosarcoma should originate from the mesenchymal tissues,
like cartilage, therefore, those arising from the skull base are
quite natural. Intracranial chondrosarcomas are also thought
to arise from the mesenchymal elements of the central ner-
vous system, such as, the primitive multipotential mesenchy-
mal cells or their mature descendents (fibroblasts, meningeal
cells, and pial cells) located within the leptomeninges, the
pia-arachnoid surrounding blood vessels or in the vessel walls,
the stroma of the choroid plexus and aberrant embryonal
cartilagenous rests (4, 7, 9-16). In the case of primary intra-
parenchymal chondrosarcoma, misplaced embryonal carti-
lagenous rests or primitive multipotential mesenchymal cells
in leptomeningeal sheaths around vessels or the vessel walls
have been suggested to be origins without definitive evidence
(3, 5, 7, 8, 10, 17-21). The tumor in present case was locat-
ed just beneath the cortex so that the leptomeningeal tissue
or a vessel in the depths of the sulcus might be a possible
origin. This hypothesis was suggested by some authors (13,
22) and our case might be an example.
Histologically, three subtypes of chondrosarcomas have
been described; classic chondrosarcoma, mesenchymal chon-
drosarcoma, and myxoid chondrosarcoma (5, 17). Most of the
primary intracranial extraosseous chondrosarcomas show a
dural involvement. However, those within the brain paren-
chyme without any attachment to the cranium or the meninges
are very rare with only seven cases reported. These include a
thalamic, three cerebellar, two frontal, and one parietal tumors
(3, 5, 8, 11, 12, 17). All of these primary intraparenchymal
chondrosarcomas were of a mesenchymal histological sub-
type. A case of radiation-induced classic chondrosarcoma of
the cerebellum occurred 16 yr after radiation therapy for a
cerebellar astrocytoma (23). However, primary intraparenchy-
mal myxoid chondrosarcoma without any dural involvement
has not been previously reported. 
The classic cranial and intracranial chondrosarcomas usu-
ally arise at the skull base and most frequently affect adults
(3, 7, 18). The classic subtype has a better prognosis than the
mesenchymal subtype (5, 7, 18). Intracranial extraosseous
mesenchymal chondrosarcoma usually occurs in the frontopari-
etal region and is highly vascular (5, 7). It is the most aggres-
sive subtype with a tendency for recurrence and metastasis
(3, 5, 17). The 5-yr survival rate is about 40%, and only occa-
sional long-term survivals have been reported (7). Cranial or
intracranial myxoid chondrosarcoma is a rare variant and only
10 cranial cases and four intracranial cases have been reported
(2, 3, 7, 9, 10, 13, 14, 19-21) (Table 1, 2). 
Calcification was more common in cranial myxoid chon-
drosarcoma. The masses were found to be of low density or
isodense on CT scan. MR imaging showed the tumors to be
of low signal intensity on T1-weighted images and of high
signal intensity on T2-weighted images. Tumors showed
modest to strong enhancements on CT and/or MRI. Severe
peritumoral brain edema was seen only in the present case.
Three patients who had undergone a gross total removal with
or without postoperative radiation therapy were in good medi-
cal condition during the follow-up period of 13 months to
three years. Two patients who had undergone a gross total
removal experienced tumor recurrences. Five patients who
underwent a partial resection with or without postoperative
radiation therapy were alive during the follow-up period of
three months to eight years (mean 5.5 yr). 
Fig. 6. On immunohistochemical studies, the myxoid chondrosarcoma shows a weak positive staining for S100 (A, ×200) and a lack of
staining for GFAP (B, ×40).
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Author/yr
Age
(yr)/
Sex
Presenta-
tion
Duration
of symp-
tom
Op
Radio-
thera-
py
Outcome F/U
Skull
x-rays
Origin Location
Cerebral
angio-
graphy
CT MRI
Table 1. Clinical features of 10 patients with cranial myxoid chondrosarcoma
Mott/
1899
28/M parasellar sella
turcica
-- - - ND ND ND ND
died
serveral   
years 
after the   
onset of 
symptoms
Naufa/
1973
27/F petrous
apex, right
foramen
lacerum
headache,
multiple 
CN 
deficits,
BS sign
24
mos
hyperos-
tosis,
destruction 
of petrous 
apex
ND ND ND PR ND died of   
pneumonia
POD 
12 days
Gacek/
1975
31/F petrous
apex, left
foramen
lacerum
headache,
multiple 
CN 
deficits
24
mos
erosion of 
petrous 
apex
avascular   
mass
ND ND PR 6,125
cGy
proton
beam
8 yr alive, no    
recurence
radiation    
necrosis
Hassounah   
et al./1985
33/F posterior
fossa, right
cranium,
T&O
ICP
symptom,
cbll sign
20
mos
calcification avascular   
mass
low dense 
mass, 
calcifi-
cation
ND GTR 5,400
cGy
proton 
beam
3 yr alive, no 
recurence
Bourgouin     
et al./1992
Three
men &
Two
women
cerebello-
pontine,
left
embryonal
resets in
the skull
base
multiple CN
deficits,
bilateral
pyramidal
syndrome
2
mos
- - Isodense 
on 
Postcon-
trast-CT
hyperintense
T2,
hypointense
T1,
PR - 3 mos 
to  
7 yr
(mean,
3 yr)
alive
17-46
(mean,
30)
parasellar,
supra-sellar,
cerebello-
pontine, 
right
embryonal
resets in
the skull
base
diplopia,
left
pyramidal
syndrome
36
mos
- - hyper-
dense,
calcifi-
cation,
mild 
enhance
N/A PR - alive
petroclinoid,
caverous
sinus, right
embryonal
resets in
the skull
base
diplopia,
right VI
nerve palsy
6
mos
- - hyper-
dense,
calcifi-
cation,
mild 
enhance
hyperintense
T2,
hypointense
T1,
PR - alive
petroclinoid,
interpedun-
culae,
suprasellar
cisterns
embryonal
resets in
the skull
base
multiple CN
deficits,
bilateral
pyramidal
syndrome
12
mos
- - hyper-
dense,
calcifi-
cation,
mild 
enhance
hyperintense
T2,
hypointense
T1,
PR - alive
cerebello-
pontine, 
right
embryonal
resets in
the skull
base
multiple CN
deficits,
bilateral
pyramidal
syndrome
7
mos
- - Isodense 
on Post-
contrast-
CT
hyperintense
T2,
hypointense
T1,
PR - alive
‐ : information is not available, ND: not done, T&O: temporo-occipital, yr: year, CN:cranial nerve, BS: brain stem, ICP: intracranial pressure,
cbll: cerebellar, mos: months, CT: computed tomography, MRI: magnetic resonance imaging, T2: T2-weighted image, T1: T1-weighted image,
enhance:enhancement, Op: operation, PR: partial resection, GTR: gross total resection, POD: postopeation day, F/U: follow-up.
55/F Sala et al./
1998
petro-
occipital
junction, right
(intradural
extension)
petrous
bone
vertigo,
vomiting,
cbll sign,
1
month
- - Calcifi-
cation,
osteolysis
hyperintense
T2,
hypointense
T1,
strong 
enhance
GTR ND died, postop 7 yr,
reoperation at 10,
16, 31, and 43
months after initial
op306 S.-H. Im, D.G. Kim, I.A. Park, et al.
Histologically, chordoma consists of epithelial cells with
abundant, foamy cytoplasm, resembling the cells in adeno-
carcinoma (24). Chondroid chordomas have morphologic
features similar to those of typical chordomas except the
additional features of cartilagenous foci resembling those of
chondroma or conventional chondrosarcoma (25). Parachor-
doma resembles chordoma histologically with nests of uni-
form-appearing, vacuolated epithelioid cells deposited in a
myxochondroid matrix, however, with a wider range of appear-
ance (26, 27). Chordoid meningioma presents as encapsulated
mass. Histologically, chordoid meningiomas were composed
of meningothelial cells, mimicking the features of chordoma
with nests and cords of epithelioid and spindle cells with abun-
dant myxoid matrix, and often associated with peritumoral
lymphoplasmacellular infiltration (28). Chordoid glioma
occurs preferentially in the third ventricle with a discrete
margin (29). Histologically, the tumor also reminiscents of
chordoma with cords and lobules of oval-to-polygonal epithe-
lioid cells in a mucoid matrix (29).
Immunohistochemically, chordoma and parachordoma
coexpress S-100 protein, cytokeratin and EMA, and the two
neoplasms differ in their detailed cytokeratin immunophe-
notype, whereas myxoid chondrosarcoma consistently lacked
cytokeratin (26). Chordoid meningiomas were immunohis-
tochemically consistently negative for S-100 protein, cyto-
keratin and EMA (30). The cells of chordoid glioma showed
diffuse and intense immunoreactivity for GFAP and vimentin,
whereas immunoreactivity for EMA and cytokeratin was
nonreactive to focally reactive (29, 31, 32). Immunohisto-
chemical finding of present case, showing slight and focal
reactivity for S-100 protein, whereas negative immunoreac-
tivity for cytokeratin, GFAP and EMA, is not compatible
with neither chordoma and related tumors, chordoid menin-
gioma nor chordoid glioma but is compatible with myxoid
Author/yr
Age
(yr)/
Sex
Presenta-
tion
Duration
of symp-
tom
Op
Radio-
thera-
py
Outcome F/U
Skull
x-rays
Origin Location
Cerebral
angio-
graphy
CT MRI
Table 2. Clinical features of 5 patients with intracranial myxoid chondrosarcoma
Scott et al./
1976
39/M 4th
ventricle
stroma of
the choroid
plexus
ICP
symptom,
cbll sign
9
mos
calcifica-
tion
avascular
mass,
hydro-
cephalus
ND ND PR ND died of
sepsis
POD 13
days
Smith and   
Davidson/
1981
12/M cerebellar
hemisphere,
left (dural
attach-
ment)
meninges ICP
symptom,
cbll sign
4
days
ND avascular
mass
hemor-
rhage,
mild
enhance,
hydro-
cephalus
ND GTR ND 13
mos
alive,
no recur-
rence
Salcman      
et al./1992
28/F falx, left sheath of
blood 
vessels
headache,
hemipare-
sis, dys-
phasia
2
mos
ND ND isodense
mass,
minimal
enhance
hyperintense
T2,
hypointense
T1,
modest 
enhance
GTR ND 22
mos
alive, 
recurred at 
10 mos 2nd 
Op &15,000 
cGy 
125I-bra-
chytherapy
died of local
Sato et al./ 
1993
43/F pineal
region
mesenchy-
mal cells in
the 
tentorium
blurred
vision, gait
disturbance
2
mos
- - multi-
lobulated,
cystic mass,
moderate
enhance
- PR 6,000
cGy
chemo-
therapy
recurrence
with
meningeal
dissemi-
nation,
POD 3 yr
Present 
case
43/M parietal
cortex, left
? ICP
symptom
2
mos
normal ND Isodense 
mass,
severe
edema,
strong
enhance
hyperintense
T2,
hypointense
T1,
strong
enhance,
severe
edema
GTR 5,940
cGy
photon
beam
3 yr alive,
no recur-
rence
‐ : information is not available, ND: not done, yr: year, ICP: intracranial pressure, mos: months, CT: computed tomography, MRI: magnetic resonance
imaging, T2: T2-weighted image, T1: T1-weighted image, enhance: enhancement, Op: operation, PR: partial resection, GTR: gross total resection,
POD: postopeation day, F/U: follow-up, 2nd: second.Primary Intracranial Myxoid Chondrosarcoma 307
chondrosarcoma. 
Primary intracranial myxoid chondrosarcoma is so uncom-
mon that no definitive statement can be made about the opti-
mal treatment and prognosis. However, most patients showed
a relatively benign clinical course during the follow-up period.
Radical excision might play an important role in the man-
agement. Postoperative radiotherapy should be considered
to prevent recurrence and progression of the tumor. 
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